An increasing number of genetic and metabolic anomalies have been determined to lead to cancer, generally fatal. Cancerous cells may spread to any body part, where they can be life-threatening. Skin cancer is one of the most common types of cancer, and its frequency is increasing worldwide. The main subtypes of skin cancer are squamous and basal cell carcinomas, and melanoma, which is clinically aggressive and responsible for most deaths. Therefore, skin cancer screening is necessary. One of the best methods to accurately and swiftly identify skin cancer is using deep learning (DL). In this research, the deep learning method convolution neural network (CNN) was used to detect the two primary types of tumors, malignant and benign, using the ISIC2018 dataset. This dataset comprises 3533 skin lesions, including benign, malignant, nonmelanocytic, and melanocytic tumors. Using ESRGAN, the photos were first retouched and improved. The photos were augmented, normalized, and resized during the preprocessing step. Skin lesion photos could be classified using a CNN method based on an aggregate of results obtained after many repetitions. Then, multiple transfer learning models, such as Resnet50, InceptionV3, and Inception Resnet, were used for fine-tuning. In addition to experimenting with several models (the designed CNN, Resnet50, InceptionV3, and Inception Resnet), this study’s innovation and contribution are the use of ESRGAN as a preprocessing step. Our designed model showed results comparable to the pretrained model. Simulations using the ISIC 2018 skin lesion dataset showed that the suggested strategy was successful. An 83.2% accuracy rate was achieved by the CNN, in comparison to the Resnet50 (83.7%), InceptionV3 (85.8%), and Inception Resnet (84%) models.
The coronavirus disease (COVID-19) is rapidly spreading around the world. Early diagnosis and isolation of COVID-19 patients has proven crucial in slowing the disease’s spread. One of the best options for detecting COVID-19 reliably and easily is to use deep learning (DL) strategies. Two different DL approaches based on a pertained neural network model (ResNet-50) for COVID-19 detection using chest X-ray (CXR) images are proposed in this study. Augmenting, enhancing, normalizing, and resizing CXR images to a fixed size are all part of the preprocessing stage. This research proposes a DL method for classifying CXR images based on an ensemble employing multiple runs of a modified version of the Resnet-50. The proposed system is evaluated against two publicly available benchmark datasets that are frequently used by several researchers: COVID-19 Image Data Collection (IDC) and CXR Images (Pneumonia). The proposed system validates its dominance over existing methods such as VGG or Densnet, with values exceeding 99.63% in many metrics, such as accuracy, precision, recall, F1-score, and Area under the curve (AUC), based on the performance results obtained.
One of the most prevalent cancers worldwide is skin cancer, and it is becoming more common as the population ages. As a general rule, the earlier skin cancer can be diagnosed, the better. As a result of the success of deep learning (DL) algorithms in other industries, there has been a substantial increase in automated diagnosis systems in healthcare. This work proposes DL as a method for extracting a lesion zone with precision. First, the image is enhanced using Enhanced Super-Resolution Generative Adversarial Networks (ESRGAN) to improve the image’s quality. Then, segmentation is used to segment Regions of Interest (ROI) from the full image. We employed data augmentation to rectify the data disparity. The image is then analyzed with a convolutional neural network (CNN) and a modified version of Resnet-50 to classify skin lesions. This analysis utilized an unequal sample of seven kinds of skin cancer from the HAM10000 dataset. With an accuracy of 0.86, a precision of 0.84, a recall of 0.86, and an F-score of 0.86, the proposed CNN-based Model outperformed the earlier study’s results by a significant margin. The study culminates with an improved automated method for diagnosing skin cancer that benefits medical professionals and patients.
Breast cancer is among the leading causes of mortality for females across the planet. It is essential for the well-being of women to develop early detection and diagnosis techniques. In mammography, focus has contributed to the use of deep learning (DL) models, which have been utilized by radiologists to enhance the needed processes to overcome the shortcomings of human observers. The transfer learning method is being used to distinguish malignant and benign breast cancer by fine-tuning multiple pre-trained models. In this study, we introduce a framework focused on the principle of transfer learning. In addition, a mixture of augmentation strategies were used to prevent overfitting and produce stable outcomes by increasing the number of mammographic images; including several rotation combinations, scaling, and shifting. On the Mammographic Image Analysis Society (MIAS) dataset, the proposed system was evaluated and achieved an accuracy of 89.5% using (residual network-50) ResNet50, and achieved an accuracy of 70% using the Nasnet-Mobile network. The proposed system demonstrated that pre-trained classification networks are significantly more effective and efficient, making them more acceptable for medical imaging, particularly for small training datasets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.